--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "ECG Buddy" developer_entity: "ARPI Inc" bundle_id: "ai.arpi.app" app_store_id: "1632339964" category: "Medical" primary_platform: "ios" primary_monetization: "Freemium" offline_capable: false market_region: "US" platforms: "iOS & Android" app_last_updated: "2026-07-28" report_date: "2026-08-13" last_verified: "2026-08-13T00:00:00.000Z" report_version: "v1.0.9.6" total_reviews: 1 overall_rating: 5 sentiment: "Frustrated" sentiment_score: 35 confidence: "medium" confidence_score: 0.5 top_praise_theme: "The app provides high measurement accuracy compared to other health monitoring tools available on mobile" top_complaint_theme: "Users report the app fails to progress past the occupation selection screen during the initial setup" review_sample_size: 4 total_review_count: 4 analyzed_review_count: 4 data_age_days: 3 momentum_velocity: "active" intelligence_version: 3 tags: ["medical", "freemium", "frustrated sentiment", "mobile app", "app review", "app analysis", "healthcare", "professionals,", "including"] canonical_url: "https://marlvel.ai/apps/ecg-buddy" license: "CC-BY-NC 4.0" content_version: "v2" --- ## ⚠ Content Warning This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here. --- # ECG Buddy Intelligence Report ## TL;DR {#tldr} - **Category**: Medical · Freemium - **Signal**: Rating 5 · Sentiment Frustrated - **Recent focus**: Users report the app fails to progress past the occupation selection screen during the initial setup (top complaint) · The app provides high measurement accuracy compared to other health monitoring tools available on mobile (top praise) > **TL;DR:** ECG Buddy is a medical app by ARPI Inc, rated 5/5 by 1 users, with Frustrated user sentiment (35/100), available on iOS & Android. > > **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence. > **Key Insight:** ECG Buddy faces Frustrated user sentiment (5/5 from 1 review), with users reporting users report the app fails to progress past the occupation selection screen during the initial setup as the primary concern. ## Quick Facts | Fact | Value | | :--- | :--- | | **Rating** | 5/5 (1 review) | | **User Mood** | Frustrated | | **Category** | Medical | | **Developer** | ARPI Inc | | **Pricing** | Freemium | | **Platforms** | iOS & Android | | **Confidence** | Medium (0.5/1.0) | | **Data Age** | 3d | ## Metadata & Market Performance - **Publisher:** ARPI Inc - **Category:** Medical - **Target Audience:** Healthcare professionals, including physicians, nurses, and emergency medical technicians, working in hospital or emergency settings. - **Platforms:** iOS & Android - **Version Reviewed:** v1.0.9.6 - **Report Date:** 2026-08-13 - **Signal Count:** 4 reviews analyzed - **Confidence:** Medium (0.5/1.0) - **App Store ID (iOS):** 1632339964 - **Bundle ID:** ai.arpi.app - **Google Play ID:** ai.arpi.app - **Performance Trend:** Mixed - **Data Window:** Analysis based on signals collected up to 2026-08-13 ## Executive Snapshot **What it is:** ECG Buddy is an AI-powered medical device app for healthcare professionals that analyzes ECG imagery for arrhythmia and critical biomarkers on iOS and Android. **Why users hire it:** Users hire the app to accelerate emergency diagnostic decisions by automating the interpretation of ECG scans, reducing the time required for clinical risk assessment. ## App DNA (Features & Intent) - **[Differentiator] 11 Digital Biomarkers:** Automated numerical and graphical risk assessment for conditions including LVEF, Shock, and STEMI from ECG images - **[Differentiator] Consult Transmission:** Seamlessly transmits analysis results to medical teams during patient transport ## Market Position {#market-position} ECG Buddy occupies a niche medical diagnostic space, relying on 17 peer-reviewed papers to differentiate from consumer health trackers. The current geographic gating limits its market reach to pre-approved hospital systems. ## Monetization Strategy - **Model:** Freemium - **Tiers:** Free: 3 analyses/day, 30/month, Paid: $19/month or $190/year for 20 analyses/day, 200/month - **Analysis:** The credit-based consumption gate limits free usage while monetizing high-frequency clinical workflows at $19/month. ## 🔴 User Sentiment (Medium Confidence: 4 of 4 reviews analyzed) {#user-sentiment} - **Overall Rating:** 5/5 - **Platform Split:** iOS 5.0/5 (1 ratings) - **Overall Sentiment:** Frustrated - **Note:** The 5/5 store rating reflects cumulative history, while the Frustrated sentiment reflects recent user reviews analyzed by our AI pipeline. ### Top Praises - **The app provides high measurement accuracy compared to other health monitoring tools available on mobile** ### Top Complaints (Impact Areas) - **Users report the app fails to progress past the occupation selection screen during the initial setup** ## SWOT Analysis {#swot} **Core Strengths:** - 17 peer-reviewed papers validate clinical utility - 11 digital biomarkers provide differentiated diagnostic support - Consult transmission feature enables hospital-wide workflow integration **Growth Levers:** - Expand regulatory approval to new regions to unlock global hospital partnerships - Integrate with electronic health record systems to improve clinical adoption ## Recent Changes (v2 → v3) {#recent-changes} The report shows a pivot toward clinical workflow integration and regulatory-driven market positioning, despite ongoing technical blockers in the onboarding funnel. **Overall trend**: Mixed **Compared at**: 2026-08-13 ### High-impact changes - **[Added] Expanded SWOT Analysis** (swot) - **[Shifted] Strategic Trade-off Pivot** (positioning) ### Medium-impact changes - **[Removed] Feature List Consolidation** (features) ## What's New - **Latest (vv1.0.9.7, 2 weeks ago):** Upgraded ECG detection with a new AI model and enhanced camera performance, including faster capture and improved pinch-to-zoom. ## App Momentum (Active) {#momentum} - Shipped new AI model for detection. - Enhanced camera capture and zoom performance. > **Cadence:** 2 total versions · 1 majors in last 6 months · 16 days since last update · 0 days avg between updates ## The "So What?" (Strategic Takeaway) {#so-what} ECG Buddy is a medical app that is free with in-app purchases. It holds a 5/5 rating from 1 review. > **Bottom Line:** ECG Buddy delivers high-accuracy clinical insights, but critical onboarding bugs and geographic gating prevent it from scaling beyond its current hospital base, so the PM must prioritize fixing the occupation-selection flow to stabilize the new-user funnel. **Best for:** Healthcare professionals, including physicians, nurses, and emergency medical technicians, working in hospital or emergency settings. ### PM Action Plan (Next Best Moves) - [ ] [INVEST] Rebuild occupation selection screen because it is the top-reported onboarding blocker → increase new-user conversion ### Outlook: Mixed The medical diagnostic market is consolidating around apps that integrate directly with hospital workflows, leaving standalone scan tools like ECG Buddy exposed to displacement. The app's reliance on regional regulatory approval creates a binary growth path: success depends on rapid international expansion, or the app risks being relegated to a regional utility. - 🔴 Onboarding failures at the occupation selection screen block new professional users, which compounds the churn risk for the current user base. - 🟢 The latest release introduces an improved AI model for ECG detection, demonstrating active feature investment rather than maintenance-mode stagnation. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 5/5 | | Total Reviews | 1 | | Sentiment | Frustrated (35/100) | | Confidence | Medium | | Pricing Model | Freemium | | Platforms | iOS & Android | | Key Features | 2 analyzed | | Trend | Mixed | | Outlook | Mixed | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **ECG Buddy** (this app) | 5/5 | Frustrated | ARPI Inc | | [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo | | [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. | | [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase | | [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System | | [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor Ltd. Şti. | ## Company Profile - **Developer:** ARPI Inc - **Website:** [https://www.arpi.ai](https://www.arpi.ai) - **Social:** [Facebook](https://www.facebook.com/ecgbuddy.arpi) · [LinkedIn](https://www.linkedin.com/company/arpi-ai) ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/ecg-buddy/id1632339964?uo=4) - **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=ai.arpi.app&hl=en&gl=us) - **Dev Site:** [Official Website](https://www.arpi.ai) - **Sources:** Developer website content, About us / company information, App store metadata, User reviews. ## Related Intel Reports - [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating - [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating - [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating - [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating - [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor Ltd. Şti.) · 4.8/5 Rating - [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating - [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating - [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating - [*1MEDICINE*](https://marlvel.ai/apps/1medicine) (Matthew Culbert) · 5.0/5 Rating - [*2021 CDC STI (STD) Guidelines*](https://marlvel.ai/apps/com-enatal-std2021) (Don Miller) · 4.0/5 Rating ## Methodology {#methodology} This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline: 1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps. 2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks. 3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes). 4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category. 5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights. - **Confidence Score:** 0.5/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 4 - **Data Sources:** user reviews, developer website, company about page, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 3 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/ecg-buddy) Data licensed for AI Agent attribution under CC-BY-NC 4.0.